Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Classement en actions #33716
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Prix de l'action
$0.4732
Dernière synchronisation: 2022-10-26
Capitalisation boursière
$7.05M
Changement (1 jour)
-0.03%
Changement (1 an)
0.00%
Pays
US
Échange GBS Inc. (GBS)

Catégorie

Historique du prix de l'action pour GBS Inc. (GBS)
Prix de clôture le plus élevé : $0.49 le 2022-10-01

Prix de clôture le plus bas : $9.14 le 2020-12-01
Historique du prix de l'action de GBS Inc. de 2020 à 2026
Performance annuelle du prix de l'action
Année Performance
2022 -69.81%
2021 -82.27%
2020 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US